Back to top
more

Aspen Pharmacare (APNHY)

(Delayed Data from OTC)

$11.29 USD

11.29
270

+0.31 (2.82%)

Updated Apr 25, 2024 01:10 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (159 out of 251)

Industry: Medical - Generic Drugs

Better trading starts here.

Zacks News

New Strong Sell Stocks for July 11th

APNHY, AHCHY, and AMK have been added to the Zacks Rank #5 (Strong Sell) List on July 11, 2022.

New Strong Sell Stocks for March 22nd

APNHY,BRY, and CSIQ have been added to the Zacks Rank #5 (Strong Sell) List on March 22, 2022.

New Strong Sell Stocks for February 28th

PRG, AGESY, and APNHY have been added to the Zacks Rank #5 (Strong Sell) List on February 28, 2022

Recent Price Trend in Aspen Pharmacare (APNHY) is Your Friend, Here's Why

If you are looking for stocks that are well positioned to maintain their recent uptrend, Aspen Pharmacare (APNHY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

ASPEN PHARMACR (APNHY) is on the Move, Here's Why the Trend Could be Sustainable

ASPEN PHARMACR (APNHY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Here's Why "Trend" Investors Would Love Betting on ASPEN PHARMACR (APNHY)

ASPEN PHARMACR (APNHY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

What Makes ASPEN PHARMACR (APNHY) a Good Fit for "Trend Investing"

ASPEN PHARMACR (APNHY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

ASPEN PHARMACR (APNHY) Upgraded to Buy: What Does It Mean for the Stock?

ASPEN PHARMACR (APNHY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Is ASPEN PHARMACR (APNHY) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Has ASPEN PHARMACR (APNHY) Outpaced Other Medical Stocks This Year?

Is (APNHY) Outperforming Other Medical Stocks This Year?

Should Value Investors Buy ASPEN PHARMACR (APNHY) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing ASPEN PHARMACR (APNHY) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy ASPEN PHARMACR (APNHY) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy ASPEN PHARMACR (APNHY) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.